Biotia raises $9 million to expand metagenomics testing, advance reimbursement, and broaden diagnostics in women’s health and ...

China’s NMPA has approved Quanterix and Innovita’s HD-X and SR-X instruments and four blood-based neurology assays for use in ...

A study found the AidaBREAST test can assess 10-year recurrence risk and predict radiation therapy benefit in early-stage ...

Clinisys adds document intelligence to its Laboratory Solution, enabling labs to convert documents into searchable, governed ...

A bipartisan Senate bill would require Medicare contractors to review local coverage requests within 60 days and increase ...

A study demonstrates correlation between measurements of biologically active ET-1 generated using Olink proximity extension ...

Thermo Fisher Scientific introduces the Nicolet RaptIR X FTIR Microscope, offering optical and infrared analysis for ...

Revvity has launched the GSP T1D 3plex kit, a fully automated, CE-IVDR-certified, multiplex autoantibody detection solution ...

Astrin Biosciences' Certitude blood test for supplemental breast cancer screening is now available to eligible women across ...

A Stanford-led study finds Resero Bio’s uRARE-seq urine cfRNA test detects bladder cancer and predicts therapy response in 683 samples.

Leica Biosystems has acquired StatLab Medical Products, expanding its anatomic pathology portfolio with consumables and ...

A phase III trial ancillary analysis found the Decipher Prostate Test predicts which intermediate-risk prostate cancer ...